6 days ago Checkmate Capital Advises NeuroSigma on Strategic Digital Health Partnership with KT Corporation - KT and NeuroSigma partner to jointly develop and commercialize neuroelectronic ADHD therapies inside and outside of Korea - Partnership...
May 19 MAIA Biotechnology, Inc. Raises $8.0Million financing led by Checkmate Capital Group. CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing first-in-class...
May 11 Elucid Secures $8 Million in Series A Funding Led by MedTex Ventures and Global Health Impact Fund BOSTON--(BUSINESS WIRE)--Elucid, a medical technology company developing AI software to enable cardiovascular disease detection, today...
Jan 28 QSAM Biosciences Closes Series B Preferred Private Placement led by Checkmate Capital. Austin, Texas, Jan. 28, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation nuclear...
Nov 2, 2020 Checkmate Capital Group Completes Seed Investment in Lactiga, Inc. PRINCETON, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), an award-winning biotherapeutics company developing...
Sep 21, 2020 NeuroSigma Receives Bridge Financing from Checkmate Capital To Support Targeted Commercialization and Global Partnering of FDA-Approved Non-Drug Treatment for Pediatric ADHD LOS ANGELES, Sept. 21,...
Apr 6, 2020 Monarch Biosciences Closes Seed Round Financing Led by Checkmate Capital Group Development of Biomaterial-based Neurovascular Stent and Platform for Local Delivery of Cell Therapies LOS...
Mar 16, 2020 Checkmate Capital Group Announces Opening of New Corporate Office in Pasadena, California LOS ANGELES, March 16, 2020 (GLOBE NEWSWIRE) -- Checkmate Capital Group, LLC (“Checkmate”) is pleased to announce that it is moving its...
